overview report {固定描述} Novavax Inc. (NVAX) rose 1.17% to close at $9.09, extending a modest recovery from recent lows. The stock continues to trade between established support at $8.64 and resistance at $9.54, with both levels likely to dictate near-term direction. The move occurred on what appeared to be normal trading activity, as the broader vaccine and biotechnology sector showed mixed sentiment.
Novavax (NVAX) Edges Higher Amid Vaccine Sector Focus – Key Levels to Watch - {个股副标题}
NVAX - Stock Analysis
3609 Comments
899 Likes
1
{用户名称}
{用户等级}
2 hours ago
{协议答案}
👍 208
Reply
2
{用户名称}
{用户等级}
5 hours ago
{协议答案}
👍 144
Reply
3
{用户名称}
{用户等级}
1 day ago
{协议答案}
👍 197
Reply
4
{用户名称}
{用户等级}
1 day ago
{协议答案}
👍 166
Reply
5
{用户名称}
{用户等级}
2 days ago
{协议答案}
👍 209
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.